Stocks · Health care · Pharmaceutical Preparations

Xeris Biopharma Holdings, Inc.

XERS Clue Score53
United States Fiscal year ends December CIK 0001867096 Results filed 5 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Beth Hecht
2 Feb 2026
See Remarks
Sell
16,667
$7.45
$124.15K
John Johnson
19 Dec 2025
Director
Sell
135,400
$7.22
$977.02K
John Johnson
13 Aug 2025
Director
Sell
107,500
$7.32
$786.46K
Dawn Halkuff
12 Aug 2025
Director
Sell
42,500
$7.28
$309.23K
Beth Hecht
20 Mar 2025
See Remarks
Sell
40,000
$5.43
$217.24K

What was left out

Form 4 filings counted 156
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 33
Sales straight out of an exercise 4
Sales at will 5
Transactions with no price 0
Shares from compensation/vesting 17,798,318
History held since 5 Oct 2021